Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Inherited epidermolysis bullosa (EB) encompasses a number of disorders characterized by recurrent blister formation as the result of structural fragility within the skin and selected other tissues.
No HPO annotations are available for this condition.
Age of onset: at birth.
Kindler syndrome (KS), a rare subtype of epidermolysis bullosa, is characterized by skin fragility and acral blister formation beginning at birth or in early infancy, diffuse cutaneous atrophy, photosensitivity (most prominent during childhood and usually decreasing after adolescence), poikiloderma, palmoplantar hyperkeratosis, and pseudosyndactyly. Mucosal manifestations are also common and include hemorrhagic mucositis and gingivitis, periodontal disease, premature loss of teeth, and labial leukokeratosis. Other mucosal findings include ectropion, urethral stenosis, and severe phimosis. Severe long-term complications of KS include periodontitis, mucosal strictures, and aggressive squamous cell carcinomas.
No consensus clinical diagnostic criteria for Kindler syndrome (KS) have been published.
KS should be suspected in individuals with the following clinical findings, skin biopsy results, and family history.
Clinical findings
Source: GeneReviews — "Kindler Syndrome"
No approved treatments are currently available for inherited epidermolysis bullosa. The disease remains an area of unmet medical need.
No clinical practice guidelines for Kindler syndrome (KS) have been published. Evaluation Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with KS, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with Kindler Syndrome
Table 6.
Recommended Surveillance for Individuals with Kindler Syndrome
System/Concern | Evaluation | Frequency
| Screen for premalignant keratoses early squamous cell carcinomas. | Starting in adolescence; annually thereafter
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
26 publications have been identified in PubMed for inherited epidermolysis bullosa. Research spans Case Report / Case Series (23%), Epidemiology / Natural History (23%), and Review / Meta-Analysis (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 23% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:42 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Source: GeneReviews — "Kindler Syndrome"
Before the onset of the photosensitivity and poikiloderma in the first few years of life, Kindler syndrome (KS) is frequently confused with other variants of epidermolysis bullosa (e.g., dystrophic, junctional, and simplex epidermolysis bullosa); however, acral skin atrophy is indicative of KS. Furthermore, in contrast to blistering in other types of epidermolysis bullosa, the blistering in KS significantly improves with age. Disorders of known genetic cause that can exhibit features of poikiloderma but are distinguishable by other clinical features are summarized . Table 3. Disorders with Features of Poikiloderma in the Differential Diagnosis of Kindler Syndrome
Gene(s) | Disorder | MOI | Clinical Characteristics |
|---|---|---|---|
Dyskeratosis congenita | XLADAR | Dysplastic nails, lacy reticular pigmentation of upper chest /or neck. Poikiloderma nail dystrophy occur in late childhood. | Oral leukoplakia. risk for progressive bone marrow failure, myelodysplastic syndrome or acute myelogenous leukemia, solid tumors, pulmonary fibrosis. ANAPC1 RECQL4 |
Rothmund-Thomson syndrome | AR | Rash that typically develops ages 3-6 mos (occasionally as late as age 2 yrs) as erythema, swelling, blistering on face, then spreading to buttocks extremities. Over mos to yrs, rash evolves into poikiloderma. Sparse hair, eyelashes, /or eyebrows. | Small size; skeletal dental abnormalities; juvenile cataracts; risk for cancer, esp osteosarcoma BLM |
Bloom syndrome | AR | Skin at birth during early infancy appears normal. During 1st or 2nd yr of life, typically following sun exposure, red, sun-sensitive rash appears on nose cheeks (sometimes also on dorsa of hands forearms). | Severe pre- postnatal growth deficiency, highly characteristic sparseness of subcutaneous fat tissue throughout infancy early childhood, short stature throughout postnatal life. Gastroesophageal reflux is common. |
CD151 | KS-like epidermolysis bullosa1 | AR | Facial freckling, poikiloderma, atrophy of skin, acrogeria of backs of hands on sun-exposed areas. Unlike KS, which presents w/blistering during childhood, 1 person described1 presented widespread blistering erosions primarily in pretibial area in adulthood. |
XPC | Xeroderma pigmentosum (XP) | AR | Sun sensitivity w/marked freckle-like pigmentation of face before age 2 yrs. Sunlight-induced ocular involvement. Greatly risk of sunlight-induced cutaneous neoplasms. |
Source: GeneReviews — "Kindler Syndrome"
System/Concern | Evaluation | Comment |
|---|---|---|
Skin issues | Comprehensive dermatologic eval for skin fragility, blistering, photosensitivity, risk for squamous cell carcinoma | — |
Eyes | Ophthalmologic consult for conjunctival involvement | — |
Mouth | Dental consult for periodontal involvement | GI tract |
counseling | By genetics professionals1 | To inform affected persons families re nature, MOI, implications of KS to facilitate medical personal decision making Family support resources |
Recommended Surveillance for Individuals with Kindler Syndrome System/Concern | Evaluation | Frequency |
Risk for skin cancer | Screen for premalignant keratoses early squamous cell carcinomas. | Starting in adolescence; annually thereafter |
Risk for oral mucosa tumors | Screen for oral ulcerations, gingivitis, periodontitis. | Starting in adolescence w/regular dental checkups Agents/Circumstances to Avoid Avoid sun exposure by using sunscreen (SFP 30) and sun-protective clothing. Evaluation of Relatives at Risk See for issues related to testing of at-risk relatives for genetic counseling purposes. |
Source: GeneReviews — "Kindler Syndrome"
Avoid sun exposure by using sunscreen (SFP 30) and sun-protective clothing.
Source: GeneReviews — "Kindler Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Kindler Syndrome"
1 trial found
Source: GeneReviews — "Kindler Syndrome"
Estimated prevalence: 1-9 in 1,000,000 (Rare).
Disease patterns and progression |
6 |
23% |
Research summaries | 5 | 19% |
Laboratory research | 5 | 19% |
New treatment approaches | 2 | 8% |
Other research | 1 | 4% |
Clinical study results | 1 | 4% |
Khanna D (2026). [PMID: 38261681](https://pubmed.ncbi.nlm.nih.gov/38261681/). *Unknown Journal*. [Other]
Supsrisunjai C (2026). [PMID: 42027988](https://pubmed.ncbi.nlm.nih.gov/42027988/). *JAAD Int*. [Basic Science / Preclinical]
El Ghouti B (2026). [PMID: 41890490](https://pubmed.ncbi.nlm.nih.gov/41890490/). *Cureus*. [Case Report / Case Series]
Wang WM (2025). [PMID: 40586126](https://pubmed.ncbi.nlm.nih.gov/40586126/). *Expert opinion on biological therapy*. [Review / Meta-Analysis]
El Hachem M (2025). [PMID: 40393138](https://pubmed.ncbi.nlm.nih.gov/40393138/). *The British journal of dermatology*. [Clinical Trial Publication]
Buianova AA (2025). [PMID: 40565224](https://pubmed.ncbi.nlm.nih.gov/40565224/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Sattar S (2025). [PMID: 39905456](https://pubmed.ncbi.nlm.nih.gov/39905456/). *BMC medical genomics*. [Basic Science / Preclinical]
Ruf H (2025). [PMID: 41318628](https://pubmed.ncbi.nlm.nih.gov/41318628/). *Orphanet journal of rare diseases*. [Case Report / Case Series]
Yang MC (2025). [PMID: 40525783](https://pubmed.ncbi.nlm.nih.gov/40525783/). *The Journal of dermatology*. [Basic Science / Preclinical]
Hitova-Topkarova D (2025). [PMID: 40729225](https://pubmed.ncbi.nlm.nih.gov/40729225/). *Reports (MDPI)*. [Epidemiology / Natural History]